Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Learn more about how the HZI, with its translational focus, will help to facilitate a faster and more targeted approach when it comes to fighting and preventing existing, emerging or recurring infectious diseases.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
From 1 July 2023, Prof Josef Penninger takes over the Scientific Management of the Helmholtz Centre for Infection Research (HZI). Here you can find content and background information for media coverage. [read more]
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
HomePressVideos & PodcastsVideos
Results 10 to 18 of total 62
Against this backdrop, the Technical University of Munich (TUM) coordinates the project Vax2Muc (“Next generation vaccines against gastrointestinal mucosal pathogens, using helicobacter pylori as a model pathogen”), an international and interdisciplinary research collaboration that sets out to develop improved, innovative, next generation subunit vaccines effective against…
On the way to clinical application, a potential drug must overcome high and cost-intensive hurdles. To enable individual innovative projects that address an important medical need to carry out the legally required clinical trials, the Else Kröner-Fresenius Foundation's ForTra gGmbH für Forschungstransfer (ForTra) supports the expensive and time-consuming production of the necessary…
Every year, the Helmholtz Association honors the best and most original doctoral theses in each of its six research fields. Since 2022, the Helmholtz Association has been awarding the Doctoral Prize in two different categories in order to recognize doctoral theses with and without an explicit application: Track A for knowledge-driven research and Track B for…
Emerging pathogens, increasing antibiotic resistance and chronic infections are among the greatest health challenges of our time. With the aim of developing new strategies and therapies against known and novel infectious diseases, the Würzburg Helmholtz Institute for RNA-based Infection Research (HIRI) was founded in May 2017. The institute is pioneering an integrated approach to…
Prof Veronika von Messling, Ministerial Director of the Federal Ministry of Education and Research (BMBF) and Chairwoman of the Supervisory Board of the HZI, explained that “We are very pleased to have Prof Josef Penninger, an outstanding researcher, as the new Scientific Director of the HZI. His appointment will accelerate internationalization and increase the scientific profiling…